Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than ...

Hematologic oncologist Eytan Stein (shown here with nurse practitioner Coleen Ranaghan) has led the development of several new drugs for acute myeloid leukemia. Acute myeloid leukemia (AML) is one of ...

Jerry Cheng, MD, Fellow, Department of Pediatrics, Mattel Children's Hospital at University of California at Los Angeles Kathleen M. Sakamoto, MD, PhD, Associate Professor, Departments of ...

If left untreated, MDS can progress to acute myeloid leukemia (AML), particularly ... on the pivotal role of mutated DDX41 protein in the pathogenesis of Myelodysplastic Syndrome (MDS), a form ...

Harry Erba, MD, PhD, professor of medicine at Duke Cancer Institute, chair of the SWOG Leukemia Committee, and co-chair of ...